Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Presentation: Conformity Assessment EvidenceTGA Australia
An introduction to conformity assessment procedures for medical devices, good manufacturing practice (GMP), some of the problems commonly experienced by sponsors and TGA, and helpful hints.
Presentation: Conformity Assessment EvidenceTGA Australia
An introduction to conformity assessment procedures for medical devices, good manufacturing practice (GMP), some of the problems commonly experienced by sponsors and TGA, and helpful hints.
Explanation of ISO standard 13485 (QUALITY MANAGEMENT SYSTEM OF MEDICAL DEVICES) in a clarified way to understand it well in a simplified way through this mode. Your comments are appreciated.
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Pallavi Christeen
The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. In addition, it may be considered a benefit that by implementing the requirements, the product will be safer for the user and this may also reduce damage and liability claims. Additional benefits may include your product being made safer for end-users. The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. If you manufacture or import a product which falls within the scope of one or more of the New Approach Directives and wish to place your product on the market in any of the member’s states of the European Economic Area (EEA), then you must apply CE marking to your product against the essential requirements of all these applicable directives.
Key Words: European Union, CE marking, New Approach Directives, EEA, Regulatory requirements.
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Akshay Anand
A presentation on Regulatory Approval Process for Medical Devices in European Union that explains in brief about the various aspects including the EU Medical Device Directives, Classifications, CE Certification, Medical Device Registration & Timelines. This was presented as a part of curriculum by Akshay Anand in JSS College of Pharmacy, Mysuru during January 2015
Medical Devices registration in Japan , quality system requirements and evaluation and investigation of medical devices in regulated countries ASEAN, China JAPAN and WHO regulations. quality and ethical considerations regulatory and documentation requirements for marketing medical devices and IVDs in regulated countries.
8 Steps You Should Be Taking to Implement an EU-MDR Compliance ProgramGreenlight Guru
The new MDR will affect all Medical Device manufacturers.
The availability of the text for the new European Medical Device Regulation allows manufacturers to start the process of assessing the impact it will have on their activities, and what they will need to do to be compliant with the revised requirements.
The MDR will overhaul some of the basic principles under which manufacturers have been working under the current MDD.
Implementing the MDR requires a structured approach, since the transition to new MDR CE certificates can last several years.
Watch the presentation here: https://www.greenlight.guru/webinar/eu-mdr-compliance-program-implementation
Explanation of ISO standard 13485 (QUALITY MANAGEMENT SYSTEM OF MEDICAL DEVICES) in a clarified way to understand it well in a simplified way through this mode. Your comments are appreciated.
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Pallavi Christeen
The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. In addition, it may be considered a benefit that by implementing the requirements, the product will be safer for the user and this may also reduce damage and liability claims. Additional benefits may include your product being made safer for end-users. The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. If you manufacture or import a product which falls within the scope of one or more of the New Approach Directives and wish to place your product on the market in any of the member’s states of the European Economic Area (EEA), then you must apply CE marking to your product against the essential requirements of all these applicable directives.
Key Words: European Union, CE marking, New Approach Directives, EEA, Regulatory requirements.
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Akshay Anand
A presentation on Regulatory Approval Process for Medical Devices in European Union that explains in brief about the various aspects including the EU Medical Device Directives, Classifications, CE Certification, Medical Device Registration & Timelines. This was presented as a part of curriculum by Akshay Anand in JSS College of Pharmacy, Mysuru during January 2015
Medical Devices registration in Japan , quality system requirements and evaluation and investigation of medical devices in regulated countries ASEAN, China JAPAN and WHO regulations. quality and ethical considerations regulatory and documentation requirements for marketing medical devices and IVDs in regulated countries.
8 Steps You Should Be Taking to Implement an EU-MDR Compliance ProgramGreenlight Guru
The new MDR will affect all Medical Device manufacturers.
The availability of the text for the new European Medical Device Regulation allows manufacturers to start the process of assessing the impact it will have on their activities, and what they will need to do to be compliant with the revised requirements.
The MDR will overhaul some of the basic principles under which manufacturers have been working under the current MDD.
Implementing the MDR requires a structured approach, since the transition to new MDR CE certificates can last several years.
Watch the presentation here: https://www.greenlight.guru/webinar/eu-mdr-compliance-program-implementation
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessmentsTGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Device Sponsor Information Day: Session 4B: Medical Devices (IVDs) - applicat...TGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Webinar NETGEAR - ReadyNAS e ReadyDR la nuova funzionalità per il Disaster Re...Netgear Italia
La funzionalità ReadyDR (disponibile solamente per i modelli dotati di OS 6.x e processore x86) per la definizione di un sistema di Disaster Recovery
che permette:
• Replica a livello Blocco Dati
• Replica di Condivisioni e di LUN iSCSI
• Replica continua o schedulata
• Limitare la banda dedicata
Webinar NETGEAR - Il nuovo WC7500 e le soluzioni appliance Prosafe per la ges...Netgear Italia
Introduzione della nuova soluzione WC7500 ed una panoramica sulle soluzioni appliance. Caratteristiche e funzionalità dei wireless controller hardware.
Webinar NETGEAR - Collegamento ad internet ovunqueNetgear Italia
Le soluzioni per il collegamento ad internet in mobilità e per installazioni temporanee. Casi di utilizzo ed una breve guida alla configurazione dei prodotti.
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...TGA Australia
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
TGA presentation: medical devices audit assessmentsTGA Australia
An overview of the medical devices audit assessment process, including explanation about the difference between Level 1 and Level 2 audits and the information sponsors are generally required to provide.
Presentation: Update from the Medical Devices BranchTGA Australia
Under Recommendation 15 of the Review of Medicines and Medical Review Regulation (MMDR) the Government agreed to greater utilisation of marketing approvals by comparable overseas regulators to support assessments of medical devices in Australia. Legislative amendments in the Therapeutic Goods Amendment (2017 Measures No. 1) Act 2018 to enact this change also included clarifications regarding preliminary assessment of applications for pre-market authorisation. This presentation will review the implementation arrangements for these changes, covering the increased options for use of overseas approvals, and the evidence requirements to support applications.
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...TGA Australia
Overview
Definitions
Regulatory framework
Mandatory and non-mandatory audits
Common issues and how to avoid them
One-page attachment to provide additional information with the application
TGA Presentation: Potential reforms for the regulation of system and procedur...TGA Australia
This presentation highlights some of the concerns related to system or procedure pack medical devices and the need for potential reforms to the current regulatory requirements in addressing these concerns.
The challenges of regulating direct to consumer digital medical devicesTGA Australia
Presentation on digital medical devices, the role of the regulator, challenges in applying the framework to digital devices, international approaches and what is the TGA doing
Devices Sponsor Information Day: 0 - Developments in medical device regulationTGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Presentation: Regulation of personalised, including 3D printed, medical devicesTGA Australia
The status of making custom made devices exempt from registration is being looked at by TGA. But with the proliferation of 3D printing, we are getting more personalised medical devices. What is the right balance to enable innovation but having the right control to avoid major issues. This session is aimed at a more senior audience.
Medical device and Patency
By MDD 93/42
Any devices including an instrument, apparatus, appliance, implant, material or other article, whether used alone or in combination, including a software or an accessory, intended by its manufacturer to be used specially for human beings or animals which does not achieve the primary intended action in or on human body or animals by any pharmacological or immunological or metabolic means, but which may assist in its intended function by such means for one or more of the specific purposes of ―
diagnosis, prevention, monitoring, treatment or alleviation of any disease or disorder;
diagnosis, monitoring, treatment, alleviation or assistance for, any injury or disability;
investigation, replacement or modification or support of the anatomy or of a physiological process;
supporting or sustaining life;
disinfection of medical devices; and
control of conception.
What is 510(k) ?
A 510(k) is a premarket submission made to FDA to demonstrate
that the device to be marketed is as safe and effective, that is,
substantially equivalent, to a legally marketed device
(section 513(i)(1)(a) FD&C act).
Medical Devices are notified as DRUGS under Drugs & Cosmetics Act. Section 3 (b) (iv) defines,
Medical Devices as “Devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals”
India had no regulation for medical devices in place prior to 2005.
The import, manufacturing, distribution and Sale of medical devices in India are overseen by the Drugs and Cosmetics Act (1940) and Rules (1945)
Control and inspection are carried out by the CDSCO, state drug controllers and central/state laboratories.
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...ulmedical
Due to a large population, increasing middle class and government plans to build tens of thousands of hospitals, there is a lot of demand for high quality medical devices in China. For many foreign medical device manufacturers, the regulatory barriers are still significant obstacles.
The medical device regulation in China is less harmonized and generally unique from other major markets. The primary challenges tend to be: actual testing, drafting standards, language barriers and license parking. These additional requirements create a delay in the registration process.
Foreign manufacturers need to specifically understand the Chinese medical device regulation in advance, and then are able to determine appropriate strategies aimed at successful China market entry.
This is the content for a live webinar, "CFDA Registration, Market Access before Investment...Solving the CFDA Challenge" delivered by UL's Tim Lin. Tim is the Senior Technical Consultant working in the Greater China Region. He majored in public health and medical device engineering, and worked as a reviewer in the Taiwan FDA for high and moderate-risk medical device and clinical trial protocol for over 5 years; and also drafted guidance for industry. He is now responsible for risk management file, usability engineering, software validation and CE MDD technical documentation.
Similar to Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's evidence and applications for ARTG inclusion (20)
Pharmacovigilance and complementary medicines - Regulatory requirementsTGA Australia
Presentation on Pharmacovigilance basics – sponsor obligations, Complementary medicine safety – Regulatory perspective and Special considerations for complementary medicine pharmacovigilance
Updates from the Pharmacovigilance and Special Access Branch TGA Australia
Presentation on using new sources of data in Pharmacovigilance, Pharmacovigilance Inspection Program (PVIP) update, International collaboration activities, Adverse Event Management System (AEMS)
Q and A
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...TGA Australia
Presentation on Legislative requirements, specific risks for IMP manufacturing, manufacturing authorisations, PIC/S Guide to GMP PE009-13 and common issues
Update on regulatory reforms from the Scientific Evaluation BranchTGA Australia
Presentation on the latest on variations, Generic Medicines Reform Program, Human cells and tissue regulation (excluded goods), Faecal Microbiota Transplantation and 2D DataMatrix codes for medicines
Update on regulatory reforms from the Scientific Evaluation BranchTGA Australia
Presentation on the latest on variations, Generic Medicines Reform Program, Human cells and tissue regulation (excluded goods), Faecal Microbiota Transplantation and 2D DataMatrix codes for medicines
Presentation on the background of medicine shortages, definitions, reporting requirements, assessment and management, Section 19A and the compliance framework
Regulatory updates from the TGA Medical Devices Branch - Part 1TGA Australia
Presentation on the review of medicines and medical devices regulation, proposed changes to some definitions and regulation of some products without a medical purpose, reclassification of medical devices (not IVD), Unique Device Identification System and post-market monitoring
Regulatory updates from the TGA Medical Devices Branch - Part 2TGA Australia
Presentation on the regulation of software including software as a medical device, proposed regulatory scheme for personalised medical devices, including 3D Printed Devices, proposed changes to the Essential Principles, Conformity Assessment Procedures, and the requirements for devices used in clinical trials, and clarifying the requirements for systems and procedure packs
SME Assist: Help to navigate the regulatory mazeTGA Australia
Presentation to provide information on TGA’s SME Assist and what the service offers, details on upcoming SME Assist events and information on where to find more help
Presentation: Updates from the Pharmacovigilance and Special Access BranchTGA Australia
This presentation covers using new sources of data in Pharmacovigilance, Pharmacovigilance Inspection Program update, international collaboration activities and Adverse Event Management System.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's evidence and applications for ARTG inclusion
1.
2. Medical Devices
Manufacturer’s evidence and applications for ARTG inclusion
Session Chair ―
Grant Bennett
General Manager, Brandwood Biomedical
Speakers / Panelists ―
Neetal Paranjape and Matthew Pitt
Therapeutic Goods Administration
Leanne Etherington
Regulatory Affairs Manager, Device Technologies Australia
3. Manufacturer Evidence and applications for
ARTG inclusion
Medical Devices
Neetal Paranjape
Application and Verification Section
Medical Devices Branch
Devices Sponsor Information Day
15 October 2015
5. What is a medical device?
• Used for human beings
• Intended purpose
– Diagnose, prevent, monitor, treat or alleviate disease or compensate for injury or
disability
– Investigation, replacement or modification of anatomy or physiological processes
– Control conception
– Accessory to a medical device as described above
• Is to be ascertained from the information provided on or in any one
or more of the following:
- Labelling
- Instructions for use
- Any manufacturer’s advertising material relating to the product
- Technical documentation
Therapeutic Goods Act 1989, section 41BD
7. ARTG inclusion
• Any medical device must be included in ARTG
• Except:
- Exempt devices (e.g. custom-made medical devices)
• Sponsor is responsible for ARTG inclusion
8. Before you start
• TGA Business Services (TBS)
– Register and get your Client ID
9. Important
Classification based on the intended purpose
Conformity assessment procedures
Essential principles for safety and performance
Post-market monitoring
11. Manufacturer evidence
• Manufacturer must apply appropriate conformity assessment
procedure to the device (quality management system and control over
the design of the device)
• Sponsor must lodge the manufacturer’s certification of the conformity
assessment with the TGA
- Except for Class I medical devices (no measuring function and/or not
supplied sterile)
• TGA conformity assessment certificate
• EC Certificate issued under MDD 93/42/EEC or AIMDD 90/385/EEC
• MRA certificates issued by EU Notified Body (with certain exceptions)
• Declarations of conformity made under Clause 7.5 of Schedule 3
(systems or procedure packs)
12. Sponsor – check before submitting
application for Manufacturer Evidence
• Manufacturer’s name is the same as the
name on the device / device label
• Address includes the street address and
country of origin
• Certificate is appropriate for the device
(Directive, Annex and the scope)
• Notified Body – accreditation
• Certificate number and its expiry date
13. TGA – what will be considered?
• Is information on the Certificate provided in English?
• Is Certificate acceptable?
– do not submit ISO certificates or FDA certificates or
European Declaration of conformity
• Is Notified Body accredited for the type of medical device?
• Do we have concerns about any information provided on the
Certificate?
• Is Certificate current (not expired)?
• Have all pages been provided (e.g. Attachments)?
15. Application for ARTG inclusion
• Must be made for a kind of device and
• Must be effective
- Made in accordance with a form and manner
approved (via TBS)
- Application fee is paid
- For the devices that must have TGA conformity
assessment certificate – such certificate is in force
- Must not contain information that is false or
misleading in a material particular
Therapeutic Goods Act 1989, sections 41FC and 41EA and Therapeutic Goods (Medical Devices)
Regulations 2002, regulation 4.1
16. Matters certified must be correct
medical device
intended purpose
correctly classified
essential principles and availability of information to substantiate compliance
application of conformity assessment procedure and availability of information
requirements (if any) relating to advertising
prohibited imports
excluded purposes (for IVD only)
information in or with the application is complete and correct
Therapeutic Goods Act 1989, section 41FD
17. Common questions
Kind of device
Intended purpose
Classification
Conformity assessment procedure
GMDN code
18. Kind of device
• Sponsor
• Manufacturer
• Device nomenclature system code
(GMDN)
• Classification
• Unique product identifier (UPI)
(for Class III devices and active implantable
medical devices)
a medical device is
taken to be of the
same kind as
another medical
device if they have
the same:
Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical
Devices) Regulations 2002, regulations 1.6 and 1.7
19. Examples of the kinds of devices
• Hypodermic needles – the same sponsor, manufacturer,
Class and GMDN Code
These devices are of the same kind
• Hypodermic needles – the same manufacturer, Class and
GMDN Code, however different sponsor
X These devices are not of the same kind
20. Intended purpose of a kind of device
• Means the purpose for which the manufacturer of the
device intends it to be used, as stated in the information
provided with the device (labelling, instructions for use,
advertising material and technical documentation)
• Intended purpose stated in the application must be
consistent with the purpose for which the manufacturer
intends the devices of the kind to be used
- specific versus general
- 500 characters only (in the application)
21. Medical devices are classified having regard
to the intended purpose of the device
Class I Class Is and
Class Im
Class IIa Class IIb Class III and
AIMD
The lowest
level
The highest
level
Therapeutic Goods (Medical Devices) Regulations
2002, Part 3 Division 3.1
22. Classification (Schedule 2)
Part 1 – Interpretation
(Transient, short-term and long-
term use)
Part 2 – Rules for non-invasive
medical devices
Part 3 – Rules for invasive and
implantable medical devices
Part 4 – Special rules for active
medical devices
Part 5 – Special rules for
particular kinds of medical
devices
23. Common questions
• Interpretation of:
- invasive and surgically invasive
- active medical device
- potentially hazardous
- duration of use
- vital physiological parameters
Dictionary, Therapeutic Goods (Medical Devices) Regulations 2002
24. Classification examples
Classification Example
Class I
Wound drainage collection
bottle
Class I sterile Sterile dressings
Class I measuring Weighing scale
Class IIa IV tubing
Class IIb Electrosurgical electrode
Class III Cardiovascular catheters
AIMD Implantable pacemakers
25. Conformity assessment procedure
• Minimum conformity assessment procedures for
different Classes of devices
• Sufficient information to demonstrate application of the
appropriate conformity assessment procedures to the
kind of device
- Certificate
- Declaration of conformity
Part 3 Division 3.2 and Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002
26. Conformity assessment procedures
Medical
device (non-
IVD) – Class*
Schedule 3 of the Therapeutic Goods (Medical
Devices) Regulations 2002
EC Certificate issued under MDD 93/42/EEC
(Declaration must be made in accordance
with Schedule 3 of the Therapeutic Goods
(Medical Devices) Regulations 2002)
Provided
under TG (MD)
Regulations
Class I
Declaration of Conformity - Part 6 N/A Regulation
3.9(1)
Class Is
Declaration of Conformity - Part 6 plus:
CAC** Production Quality Assurance - Part 4
Annex II.3 OR
Annex V (‘sterility aspects’ or equivalent
wording)
Regulation
3.9(2)
Class Im
Declaration of Conformity - Part 6 plus CAC issued
under either:
Verification - Part 3 or
Production Quality Assurance - Part 4 or
Product Quality Assurance - Part 5
Annex II.3 or
Annex IV ( specific batches are included
on the certificate) or
Annex V or
Annex VI (‘metrology aspects’ or
equivalent wording)
Regulation
3.9(3)
Class IIa
CAC Full Quality Assurance - Part 1 (excluding clause
1.6 Design Examination) or
Declaration of Conformity - Part 6 plus CAC issued
under either:
Verification - Part 3 (for non-sterile devices) or
Production Quality Assurance - Part 4 or
Product Quality Assurance – Part 5 (for non-
sterile devices)
Annex II.3 or
Annex IV (for non-sterile devices where
specific batches are included on the
certificate) or
Annex V or
Annex VI (for non-sterile devices)
Regulation 3.8
* devices other than devices to be used for a special purpose (medical device used for a special purpose means a medical device to which regulation 3.10 applies; Part 7 of
Schedule 3 provides procedures that must be applied to medical devices used for a special purpose)
** CAC – conformity assessment certificate (conformity assessment certificate means a certificate issued under section 41EE of the Act, this means certificate issued by the TGA) or
Certificate issued under MRA in accordance with the relevant Part of Schedule 3 of the Therapeutic Goods (Medical Devices) Regulations 2002
27. Conformity Assessment Procedures
Medical
device (non-
IVD) – Class*
Schedule 3 of the Therapeutic Goods (Medical
Devices) Regulations 2002
EC Certificate issued under MDD 93/42/EEC
(Declaration must be made in accordance
with Schedule 3 of the Therapeutic Goods
(Medical Devices) Regulations 2002)
Provided
under TG (MD)
Regulations
Class IIb
CAC Full Quality Assurance - Part 1 (excluding clause
1.6 Design Examination) or
CAC Type Examination - Part 2 plus CAC issued
under either:
Verification - Part 3 (for non-sterile devices) or
Production Quality Assurance - Part 4 or
Product Quality Assurance – Part 5 (for non-
sterile devices)
Annex II.3 or
Annex III plus either:
Annex IV (for non-sterile devices where
specific batches are included on the
certificate) or
Annex V or
Annex VI (for non-sterile devices)
Regulation 3.7
Class III
CAC Full Quality Assurance - Part 1 (including clause
1.6 Design Examination) or
CAC Type Examination - Part 2 plus CAC issued
under either:
Verification - Part 3 (for non-sterile devices) or
Production Quality Assurance - Part 4
Annex II.3+II.4 or
Annex III plus either:
Annex IV (for non-sterile devices where
specific batches are included on the
certificate); or
Annex V Regulation 3.6
AIMD
90/385/EEC (AIMDD)
28. Examples
• Scope of the certificate
- Device in the application urinary catheter
- EC Certificate scope needles
X Not acceptable
• Minimum conformity assessment procedure
- Device in the application Class IIb
- EC Certificate Annex V (Production quality assurance)
X Not acceptable
- EC Certificate Annex V + Annex III (Type examination
certificate)
Acceptable
29. Global Medical Device Nomenclature (GMDN)
• GMDN code
- one of the characteristics that defines the kind of
device
- is to be consistent with the intended purpose of the
device
• Linked to Class of medical device
- relevant preferred term or
- for Class I - the relevant template term (or preferred
term if there is no relevant template term)
• Manufacturer’s responsibility
31. Information provided in the application
• Do not provide information that is not relevant in the
application, for example:
– Declaration of conformity made under EU Medical
Device Directive
– Test reports
• Ensure ‘Device Product Characteristics’ section in the
application is correctly filled in
32. One page document
• Describe the device and intended purpose if needed in
more detail
• Cite the classification rules in accordance with
Schedule 2 of the Regulations and provide justification
where required
• Explain how the kind of device is covered under the scope
of certificate included in Manufacturer Evidence
• Make sure all the information is complete and correct
• Do not attach more than one page
33. Where do we go from here?
Ensure all information
provided in the
application is correct
Any application may be selected
for audit
Some applications must be selected for
audit
34. More information and guidance
Australian Regulatory Guidelines for Medical Devices
(ARGMD ) – via the TGA website
ComLaw : Database of Commonwealth law
Therapeutic Goods Act 1989, Chapter 4
Therapeutic Goods (Medical Devices) Regulations 2002
TGA website: News, consultations, guidance, subscribe
to updates
Contact the TGA Medical Devices Branch
devices@tga.gov.au 1800 141 144
39. Today
Manufacturer’s Evidence and ARTG inclusions:
Application processes by classification
Preparation and checks to do
TGA Business Services submission forms
Common problems and ways to prevent or avoid them!
Some slides have legislation/guidance references where you can find more
information for your specific needs.
Not covered:
• Conformity Assessment Procedures
• Audits
• Systems and Procedure Packs, IVDs
• Class III/AIMD UPI and Variants
• Clinical Evidence & Risk Assessment compliance
40. Sponsor Process Overview
Class I
Preparation
Complete & submit form
No application fee
Auto-inclusion
ARTG Certificate available
Class Is, Im, IIa or IIb
Preparation
(+ Manufacturer’s Evidence is
accepted on TGA Bus Serv)
Complete & submit form
Fee payment is processed
(currently $960)
TGA reviews application and
may:
• select for audit
• approve the application
• reject the application
If approved:
ARTG Certificate available
Class III/AIMD
Preparation
(+ Manufacturer’s Evidence is
accepted on TGA Bus Serv)
Complete & submit form
Fee payment is processed
(currently $1,235)
TGA selects for audit
Sponsor submits audit file &
pays audit fee
TGA reviews audit file and may
• Ask further questions
• Approve the application
• Reject the application
If approved:
ARTG Certificate available
41. Manufacturer’s Evidence
The first step in the TGA application process for Classes:
• I (supplied sterile or measuring)
• IIa and IIb
• III and AIMD
Consider this step as a key part of your Preparation
• Submit on TGA Business Services website well in advance
Manufacturer’s Evidence for medical devices (non-IVD) can be:
• CE Certificate (MDD or AIMDD)
• TGA Conformity Assessment Certificate
• System or Procedure Pack Declaration to Clause 7.5
• MRA Compliance Certificate
44. 1. Complete the fields
accurately using the
details on the
Evidence.
2. Attach the Evidence
ONLY
3. Validate (if successful
the submit button
appears)
4. Submit
45. What is a medical device ARTG application?
ARTG Inclusion is for a Kind of medical device
(Section 41BE of The Act)
A medical device is of the same ‘kind’ if it has the same:
• Classification
• GMDN code
• Legally defined manufacturer
• Sponsor
And for Class III or AIMD, if it has the same:
• Unique Product Identifier (UPI)
46. Application Preparation
Know your product!
Product information from manufacturer (brochures, labelling,
instructions for use)
Is it a medical device?
How is it packaged and supplied?
How is it identified and tracked?
Who is involved in manufacture and supply?
Contain any medicine or materials of animal origin?
47. Application Preparation
Information for the TGA Business Services Device Application form
• Is it:
? Sterile
? Invasive
? Reusable/Single Use
? Active
? Single product/system/procedure pack
? Containing a medicine
? Containing material/ingredients of
microbial/recombinant/GMO/animal/human origin
• Does it have appropriate evidence of Conformity Assessment?
• And have you submitted Manufacturer’s Evidence if Class Is/m, IIa, IIb,
III or AIMD?
48. Early checks to do
Check What? How?
Is it a medical
device?
• Check according to the TGA definition Refer to:
• Section 41BD of the Act
Risk
Classification
• Check correctly classified by
manufacturer, according to TGA
Classification Rules
Refer to:
• Schedule 2 of The Regulations
(Regulation 3.2)
Is the GMDN
appropriate?
Note:
Selection of the
GMDN is the
manufacturer’s
responsibility
• Can you see, based on product
information, that the GMDN makes
sense?
• Does it reflect the intended purpose?
• Must be a preferred term unless the
device is Class I (template term
allowed)
• Check if the GMDN is on the TGA
database
Refer to:
• Regulation 1.7
• ARGMD Section 10
Use:
• Product information (e.g. labelling, IFU,
advertising)
Note:
• If the GMDN code is not in the TGA database,
ask for it to be added in advance by email to
ebs@tga.gov.au
Legally
defined
manufacturer
• Verify who the legally defined
manufacturer is
Note:
(manufacturer is: responsible for the design,
production, packaging and labelling of the
device before it is supplied under their name )
Refer:
• Section 41BG of the Act
Ensure:
• named manufacturer on label, IFU,
certificates, advertising, etc. is consistent
49. Early checks to do
Check What? How?
Conformity
Assessment
Evidence
• Need to check the appropriate
level and route is held by the
manufacturer
Dependant on Classification
• Check Evidence is valid and
correct
Make sure the certificate is
accepted on TGA Business
Services for Class Is, Im, IIa, IIb,
III and AIMD
Refer to:
• ARGMD Section 5 & 6
• Check CE certificates contain all the
information needed to be valid (ARGMD
Section 7)
Essential
Principles (EP)
Compliance
• Are you confident and do you
have evidence that the medical
device meets the Australian EP?
Note: Australian EP is NOT exactly
the same as the European Essential
Requirements (ER)
Refer to:
• Schedule 1 of The Regulations
(Regulation 2.1)
• ARGMD Section 8
Options:
• Obtain completed EP Checklist
• Obtain other documents to assure you that
this is being met and is available
50. Early checks to do
Definitions
Check What? How?
Active medical device
• These definitions have very specific terminology
and need to be carefully checked
• If your product falls into any of these categories
it could have a significant impact on the device
class
Refer to:
• Regulation 1.3
(Dictionary)
Reusable surgical
instrument
Refer to:
• Regulation 1.3
(Dictionary)
Medical devices with a
measuring function
Refer to:
• Regulation 1.4
Central Circulatory
System
Refer to:
• Regulation 1.3
(Dictionary)
51. Early checks to do
Class III & AIMD
Check What? How?
Unique
Product
Identifier
(UPI)
• Check that you have a valid UPI and can
demonstrate this to the TGA
Note:
UPI is the unique identifier given to the device by its
manufacturer to identify the device and any
variants
Refer to:
• Regulation 1.6
• ARGMD Section 10
Try to:
• Ensure the UPI is consistent on AU
DoC, CE Certificates, Labelling, IFU,
advertising and other documents
Variants • Check that all devices you want to include in
each application have allowable variants and
you can demonstrate this to the TGA.
Note:
Variant means “A medical device, the design of which
has been varied to accommodate different patient
anatomical requirements or any other variation
approved by the secretary for the purposes of this
definition, if the variation does not change the
intended purpose of the device”
Refer to:
• Regulation 1.3 (Dictionary)
• ARGMD Section 10
Try to:
• Demonstrate the variant is
acceptable by provision of brochure,
labelling or other technical
documents
52. Early checks to do
Is your Kind of Device subject to a mandatory audit?
Refer to: Section 41FH of the Act; Regulation 5.3; ARGMD section 11 (below)
Implantable:
Intraocular Lens
Contraceptive Device
Breast Prostheses containing material of fluid consistency (other than
water or saline solution only)
Prosthetic Heart Valve
Intended for disinfecting another medical device
Class AIMD
Class III:
procedure packs using a Clause 7.5 Declaration of Conformity
Not assessed by the EC or EFTA Mutual Recognition Agreements
Intraocular Visco Elastic Fluids
Barrier indicated for contraception/prevention of transmission of disease
in the course of penile penetration during sexual intercourse
53. Before you submit on TGA Business Services
Obtain Manufacturer’s Australian Declaration of Conformity
• To document the:
o ‘kind of medical device’
o standards applied
o compliance with the Australian Essential Principles and legislation
• Make sure you have the right template for class and conformity route
• See https://www.tga.gov.au/industry/devices-forms-declaration-conformity.htm
Ensure a written agreement is in place for post-market monitoring,
vigilance and reporting obligations
• Between AU Sponsor/Distributor and Manufacturer
• For example, covering:
o complaints and incident monitoring/reporting
o Annual event reporting, etc.
54.
55.
56. TGA Application Forms
Information required is dependant on risk classification
• When you select the class the form will populate the various fields to be completed
• Common for all classes:
• Intended Purpose
• make sure this is consistent with other information in the application
• Manufacturer Name and Address
• GMDN Code and Description
• Sponsor’s Declaration
57. TGA Application Forms
Class Information needed in eBS
I • 20-30 Device Product Characteristics questions (Yes/No)
I(sterile)
I(measuring)
IIa
IIb
• 11 Specific Details questions (Yes/No)
• Select available Manufacturer’s Evidence
III
AIMD
• 11 Specific Details questions (Yes/No)
• Select available Manufacturer’s Evidence
• UPI, Functional Description, # of devices covered & variants
• Attach Design/Type Examination Certificate
58. Additional Information
• Information in the TGA Business Services form is not always enough to give the TGA
assessor a good understanding of the ‘kind of medical device’.
• If there is conflicting information, then the TGA assessor is likely to request
information as part of an audit
• This causes more work and delays for both the Industry and TGA
• If you know up front that there is additional information that will help the assessor,
then you might want to attach a ONE PAGE ONLY document before you submit
59. ONE page attachment
Examples include:
• A Picture/diagram of the device to show:
• the device itself
• its packaging or components
• how it interacts with users or patients
• A description of the device (not the intended purpose)
• A description of the mechanism of action (how it works)
• How the device is included in the scope of the CE Certificate
61. Some Possible Problems
Manufacturer’s Evidence applications:
Two or more certificates/documents attached – must be ONLY ONE per application
ISO, EN, FDA, European Declarations, EC Design/Type Examination Certificates attached to Manufacturers
Evidence applications
Pages of CE Certificates/Evidence submitted are missing
Certificate is not in English
Information on the form doesn’t match the Evidence attached
For Changes:
Additional information needed if change in Manufacturer Name/Address
Scope of the certificate has changed – If so, this must be answered YES on the application
Medical Device Applications:
‘Intended purpose’ doesn’t reflect GMDN code, Class, or specific details in the TGA form
Product Characteristics aren’t consistent with the GMDN code, Class, or intended purpose, etc.
Route of conformity (EC Certificate Annex) is not appropriate for the Class
The TGA can’t identify where the product is covered in the EC Certificate scope
The application isn’t linked to the correct Manufacturer’s Evidence
Attachments contain irrelevant or conflicting information
Other Administrative problems:
Fee payment not processed quickly
Spelling errors
62. Ways to avoid problems
Do your preparation! Time spent before submitting is well worth it and will
increase your success rate
Develop a good relationship & contract with manufacturer
Make sure you have the correct and current Manufacturer’s Evidence,
matching the medical device (and clearly identifiable in the scope)
Accurately complete the TGA Business Services forms so that they properly
represent the medical device you want to include
Don’t submit extra certificates/documents that aren’t useful
Make sure you understand your product and have verified the information
you are submitting is correct in advance
Make sure any extra information submitted is concise and accurate
63. References
• The Act
Therapeutic Goods Act 1989
• The Regulations
Therapeutic Goods (Medical Device) Regulations 2002
• ARGMD
Australian Regulatory Guidance for Medical Devices
(version 1.1 May 2011)